Literature DB >> 29799399

Evaluation of germ-cell neoplasia in situ entity in testicular tumors.

Mehmet Akyüz1, Ramazan Topaktaş1, Ahmet Ürkmez1, Orhan Koca1, Metin İshak Öztürk1.   

Abstract

OBJECTIVE: Germ-cell neoplasia in situ (GCNIS) is accepted as the precursor of the testicular tumors. The aim in our study is to compare the lymphadenopathy and metastasis parameters in patients diagnosed with testicular tumor with or without GCNIS based on pathological evaluation.
MATERIAL AND METHODS: Data from 108 patients who underwent orchiectomy for testicular tumor between January 2007 and December 2014 in our clinic were retrospectively analyzed and included in the study. Patients were divided into two groups based on the pathology reports as GCNIS or not. Groups were compared regarding lymphadenopathy, metastasis, tumor marker levels, tumor size, lymphovascular invasion, rete testis invasion. Mann-Whitney U test was used for statistical evaluation.
RESULTS: Mean age of the patients included in the study were calculated as 34.6±9.3 years. Eighty-five (78.7%) patients had GCNIS, while 23 (21.3%) of them had not. In terms of metastasis, lymphadenopathy, marker levels, tumor size, lymphovascular invasion and rete testis invasion, no statistical significant difference were observed between two groups (p>0.05).
CONCLUSION: In our study, no statistical significant difference was observed on the prognostic factors concerning the GCNIS entity, which is reported frequently in testicular tumor pathologies. For presently these findings show us that GCNIS cannot be used as a prognostic factor.

Entities:  

Year:  2018        PMID: 29799399      PMCID: PMC6788558          DOI: 10.5152/tud.2018.48855

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  16 in total

1.  Carcinoma in situ of the testis.

Authors:  T B Hargreave
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

2.  Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?

Authors:  Adam P Vogt; Zhengjia Chen; Adeboye O Osunkoya
Journal:  Hum Pathol       Date:  2010-06-22       Impact factor: 3.466

3.  Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features.

Authors:  C M Coffin; S Ewing; L P Dehner
Journal:  Arch Pathol Lab Med       Date:  1985-06       Impact factor: 5.534

4.  Prevalence of testicular intraepithelial neoplasia in healthy males.

Authors:  Jörg Linke; Volker Loy; Klaus-Peter Dieckmann
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

Review 5.  Increasing incidence of testicular cancer worldwide: a review.

Authors:  Eric Huyghe; Tomohiro Matsuda; Patrick Thonneau
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

Review 6.  Intratubular germ cell neoplasia of the testis: testicular intraepithelial neoplasia.

Authors:  Rodolfo Montironi
Journal:  Eur Urol       Date:  2002-06       Impact factor: 20.096

Review 7.  An overview of testicular germ cell tumors.

Authors:  Armita Bahrami; Jae Y Ro; Alberto G Ayala
Journal:  Arch Pathol Lab Med       Date:  2007-08       Impact factor: 5.534

Review 8.  Diagnosis and treatment of testicular cancer.

Authors:  Joel Shaw
Journal:  Am Fam Physician       Date:  2008-02-15       Impact factor: 3.292

Review 9.  Global incidence and outcome of testicular cancer.

Authors:  Thurkaa Shanmugalingam; Aspasia Soultati; Simon Chowdhury; Sarah Rudman; Mieke Van Hemelrijck
Journal:  Clin Epidemiol       Date:  2013-10-17       Impact factor: 4.790

10.  The histologic features of intratubular germ cell neoplasia and its correlation with tumor behavior.

Authors:  Abbas Basiri; Saeed Movahhed; Mahmood Parvin; Maziar Salimi; Gholam Hossein Rezaeetalab
Journal:  Investig Clin Urol       Date:  2016-05-03
View more
  1 in total

1.  Pluripotent Very Small Embryonic-Like Stem Cells in Adult Testes - An Alternate Premise to Explain Testicular Germ Cell Tumors.

Authors:  Ankita Kaushik; Deepa Bhartiya
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.